Extensive Stage Small Cell Lung Carcinoma
Also known as: Extensive Stage-small Cell Lung Cancer / Extensive Stage Lung Small Cell Cancer / SCLC,Extensive Stage / Extensive-Stage Small-Cell Lung Cancer / Extensive Stage Small Cell Lung Cancer / Small Cell Lung Cancer Extensive Stage / Extensive-stage Small Cell Lung Cancer (SCLC) / Extensive Stage Lung Small Cell Carcinoma / SCLC, Extensive Stage / Extensive-Stage Small Cell Lung Cancer / Small Cell Lung Extensive Stage
Drug | Drug Name | Drug Description |
---|---|---|
DB11714 | Durvalumab | An antineoplastic monoclonal antibody used to treat urothelial carcinoma and locally advanced, unresectable non-small cell lung cancer. |
DB15442 | Trilaciclib | A CDK4 and CDK6 inhibitor to reduce the risk of chemotherapy induced myelosuppression. |